Molecular Imaging of Late Somatostatin Receptor–Positive Metastases of Renal Cell Carcinoma in the Pancreas by Radiolabeled 111In SRS Octreotide Scan : A Rare Differential Diagnosis to Multiple Primary Pancreatic Neuroendocrine Tumors

#1565

Introduction: Somatostatin-Receptor Scintigraphy (SRS) has a sensitivity and specificity for pancreatic NETs (pNETs) of 90 and 80% respectively. SRS is indicated as first staging procedure and one of the most sensitive imaging modalities for well-differentiated neuroendocrine tumors, based on imaging of somatostatin receptors (SSRTs).

Aim(s): To report 111In SRS scan ability in detecting lesions of RCC origin.

Materials and methods: A radiolabeled 111In SRS scan was used.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Dimitriadis G

Authors: Dimitriadis G, Davies L, Randeva H, Weickert M,

Keywords: SRS, pNET, SSRTs, RCC,